FDA approves Bausch + Lomb and Clearside’s XIPERE for macular edema

The FDA has approved XIPERE for the treatment of macular edema associated with uveitis

Genentech’s new treatment for wet AMD receives FDA approval

Susvimo's new therapeutic approach for wet AMD may help patients maintain their vision with as few as 2 treatments per year

Dry AMD: The Benefits of Remote Monitoring

How data from remote monitoring centers create better opportunities for treating patients with dry age-related macular degeneration.